Buccal Fat Removal: Types, Procedure, and Benefits — Cost, Top Hospitals & Success Rates | MyMedicPlus

Buccal fat removal (bichatectomy or bichectomy) is a minimally invasive oral surgical procedure that removes the buccal fat pad — a discrete encapsulated fat pad located in the lower cheek between the buccinator and masseter muscles — to reduce cheek fullness, narrow the lower face, and create a more sculpted, defined facial contour. The procedure has surged in popularity in recent years, driven in part by the 'snatched' or 'model face' aesthetic trend, and is increasingly requested by younger patients seeking cheekbone definition and facial slimming. However, it requires careful patient selection because the buccal fat pad naturally decreases in volume with age — removal in young patients creates an aged, hollowed appearance in their 40s and 50s that is very difficult to reverse.

The operation is performed through two small incisions (approximately 1cm each) made inside the mouth in the upper buccal sulcus — no external scars are created. The surgeon bluntly dissects through the buccinator muscle to reach the buccal fat pad, gently delivers it into the oral cavity, and excises the appropriate volume (typically 3-5ml per side). The incisions are closed with absorbable sutures. The procedure takes 30-45 minutes and is performed under local anaesthesia (with or without oral sedation) as a day case.

Buccal fat removal is a permanent and irreversible procedure — the fat pad does not regenerate once removed. This makes patient selection and consultation critically important. The procedure is appropriate for adults with persistent lower cheek fullness that persists despite being at a healthy weight, who have realistic expectations and understand that results become more pronounced (and may appear over-corrected) with natural age-related facial volume loss. It is not appropriate for patients who are underweight, who have naturally thin faces, or who are under 20 years of age.

Buccal fat removal addresses lower cheek fullness (chubby cheeks) that is attributable to enlarged or prominent buccal fat pads rather than generalised facial adiposity or masseter hypertrophy. The buccal fat pad contributes to the rounded, baby-faced appearance that some patients find aesthetically undesirable in adulthood. The procedure creates the appearance of more defined cheekbones, a slimmer lower face, and a more angular jaw-to-cheek transition.

Buccal fat removal is sometimes combined with other facial contouring procedures — masseter botulinum toxin (for jaw slimming by reducing masseter muscle bulk), chin augmentation (to improve overall facial proportions), rhinoplasty, or facelift — to achieve comprehensive facial reshaping. It is important to distinguish buccal fat pad hypertrophy from masseter hypertrophy (muscle bulk causing jaw width) and from generalised facial fat (which would be better addressed by weight management rather than surgery). Pre-operative assessment including facial analysis with photographs, digital morphing, and clinical palpation helps identify the specific anatomical contributor to facial fullness.

The ideal candidate for buccal fat removal is an adult aged 25 or older at their stable adult weight, with a full, rounded lower face attributable to prominent buccal fat pads, who has maintained this facial appearance through adulthood with minimal age-related change. Patients must be at a healthy, stable weight — weight fluctuations affect facial fat distribution, and patients planning significant weight loss should defer the procedure until weight is stable, as generalised facial fat loss may naturally slim the cheeks without surgery.

Contraindications include: patients under 25 years of age (the buccal fat pad continues to involute into the mid-20s); thin or narrow-faced individuals (who will appear hollowed and aged, not refined); patients with naturally prominent cheekbones who will be left with an excessively gaunt appearance; patients with significant masseter hypertrophy (where botulinum toxin jaw slimming rather than fat removal is the appropriate treatment); and patients with unrealistic expectations or a dysmorphic body image concern. The procedure is not indicated for patients who want to address ageing-related facial hollowing (which requires volume addition, not removal) or for patients with Parry-Romberg syndrome or other facial lipoatrophy conditions.

The standard approach is bilateral simultaneous buccal fat pad excision through intraoral incisions, as described above. Volume of fat removed is tailored to individual anatomy — over-removal is the primary technical error, as the goal is refinement rather than maximal excision. Some surgeons prefer conservative partial excision to avoid over-correction, particularly in younger patients who will experience natural volume loss with age.

For patients seeking facial slimming without surgery, non-surgical alternatives include: masseter botulinum toxin (Botox jaw slimming) — reduces lower face width by atrophying the masseter muscle over 3-4 months, with effect lasting approximately 6 months; buccal fat pad injection with deoxycholic acid (analogous to Kybella/Belkyra used for submental fat) — this approach is experimental, off-label, and not yet validated by robust clinical trials. Facial liposuction of the cheeks (jowl and lower cheek area) can address generalised lower face adiposity but cannot precisely target the buccal fat pad. No non-surgical treatment approaches the precision or permanence of surgical buccal fat pad excision.

The operating surgeon reviews the patient's complete medical history, current medications, and desired outcomes before finalising the surgical plan. Preoperative digital photography and computer simulation allow the surgeon and patient to align expectations and visualise potential results. Anaesthetic choice — general anaesthesia or intravenous sedation with local anaesthesia — is decided in consultation with the anaesthesiologist based on procedure complexity, patient health status, and patient preference. Postoperative care instructions, including wound care, activity restrictions, and follow-up scheduling, are provided in written form before surgery.

When appropriately selected and performed conservatively, buccal fat removal creates a more defined, contoured lower face with more visible cheekbones and a slimmer facial silhouette. The change is permanent and immediately apparent (after swelling resolves), with no ongoing maintenance required. The intraoral incisions leave no visible scars. The procedure is relatively simple with a short recovery and low complication rate at experienced centres.

Patients who achieve good results typically describe an improved sense of facial balance and proportion, with a face that appears consistent with their overall body size rather than retaining disproportionate childhood facial volume into adulthood. When combined with masseter botulinum toxin in patients with concurrent jaw muscle bulk, the combination effect on lower face slimming can be dramatic. Results are most reliably assessed at 3-6 months when all swelling has resolved and the new cheek contour is fully apparent.

The most clinically important long-term risk of buccal fat removal is over-correction — progressive facial hollowing as natural age-related fat loss reduces facial volume with ageing. Many facial surgery experts caution that patients who undergo buccal fat removal in their 20s or early 30s may develop a gaunt, skeletal facial appearance in their 40s and 50s that is cosmetically adverse and very difficult to address (requiring fat grafting). This is the central reason for careful patient selection and age thresholds.

Immediate surgical risks include: damage to the parotid duct (which crosses the operative field — injury causes parotid fistula, a serious but rare complication); injury to branches of the facial nerve (buccal branch — transient paresis occurs rarely; careful anatomical knowledge prevents permanent injury); oral infection (the wound is in a contaminated oral environment — prophylactic antibiotics and chlorhexidine mouthwash reduce risk); haematoma; wound dehiscence inside the mouth; and dry mouth or altered salivation if the parotid duct is compressed. Asymmetry of result occurs in 5-10% of patients and may require revision. The procedure cannot be reversed — once removed, the buccal fat pad does not regenerate, and restoration requires fat grafting.

Recovery from buccal fat removal is generally straightforward. Intraoral swelling causes temporary facial fullness in the first 2-3 weeks — patients should be counselled that the face may actually appear fuller immediately post-operatively, with the final slimming effect visible at 3-6 months as swelling fully resolves. A soft diet (avoiding foods that require wide mouth opening or chewing) is recommended for 1-2 weeks while intraoral incisions heal. Chlorhexidine mouthwash is used 2-3 times daily for wound hygiene.

Pain is typically mild and manageable with simple analgesics. Most patients return to work and social activities within 3-5 days. Strenuous activity is avoided for 1-2 weeks. No external dressings or suture removal is required (absorbable sutures dissolve). Follow-up appointments at two weeks (wound check and healing assessment) and three months (result assessment and photography) are standard. Patients are counselled that the final result continues to evolve over 6-12 months.

Buccal fat removal in the USA costs USD 3,000-5,000 including surgeon fee, facility, and anaesthesia — it is one of the more affordable facial surgical procedures given its technical simplicity. UK private costs are GBP 2,500-4,500. The procedure is not covered by insurance as it is purely cosmetic.

Medical tourism for buccal fat removal offers further savings: Turkey: USD 800-1,800; South Korea (a popular destination specifically for facial contouring procedures): USD 1,500-3,000; Thailand: USD 1,200-2,500; Mexico: USD 1,000-2,000. Many cosmetic surgery tourism packages combine buccal fat removal with other facial procedures (rhinoplasty, chin implant, masseter BTX) at combined pricing. Patients should verify their surgeon's experience specifically in facial anatomy and buccal fat procedures — given the risk of over-correction and parotid duct injury, operator experience matters considerably.

Masseter botulinum toxin (Botox, Dysport) injected into the masseter muscles slims the lower face by causing disuse atrophy of the jaw muscles — effective for patients whose lower face width is driven by masseter hypertrophy rather than buccal fat volume. Results last 4-6 months and require repeat treatment. This is a reversible, non-surgical option for lower face slimming and is preferred as a first step before committing to permanent surgical fat removal.

Facial contouring with fillers (chin, jaw, or cheek augmentation) can rebalance facial proportions without removing anything — by improving definition of the jawline, chin, and cheekbones, an illusion of a slimmer midface can be created without excising fat. This approach may be preferable for patients who are ambivalent about the permanence of buccal fat removal. Weight management is appropriate for patients with generalised facial adiposity contributing to overall facial fullness — buccal fat removal will not address facial fat beyond the buccal fat pad itself.